INFLUENCE OF QUINAPRIL ON THE REGULATORY-ADAPTIVE STATUS OF PATIENTS WITH CHRONIC HEART FAILURE HYHA CLASS I: RESULTS OF NOT COMPARATIVE STUDY
https://doi.org/10.20996/1819-6446-2012-8-4-526-530
Abstract
Aim. To assess effects of quinapril on the regulatory-adaptive status (RAS) in patients with chronic heart failure (CHF) NYHA class 1 and arterial hypertension (HT). Material and methods. Patients (n=49) with CHF NYHA class I and HT stage I–II (25 men and 24 women, aged 52.5±8.4 years) were included into an open noncomparative study. A cardio-respiratory synchronization (CRS) test, 6 minute walk test, treadmill test with evaluation of the maximal oxygen uptake during exercise, ambulatory blood pressure monitoring, echocardiography , determination of N-terminal prohormone of brain natriuretic peptide (NT-proBNP) plasma level were performed at baseline and after 6 months of quinapril therapy. Results. The quinapril treatment (average daily dose 17.3±7.9 mg) improved myocardium structural and functional parameters, increased the exercise tolerance, reduced neurohumoral activity , improved the RAS according to CRS test: increase in synchronization range of cardiorespiratory cycles per minute from 8.0±2.1 to 11.0±2.5 (Δ27.3%; p<0.01), as well as RAS index from 52.6±7.8 to 89.7±8.9 (Δ41.4%; p<0.01), and decrease in the duration of CRS development at the minimal border of cardiac cycles from 15.5±3.5 to 12.9±2.8 (Δ15.8%; p<0.01). Conclusion. Quinapril has a positive effect on the RAS in patients with CHF NYHA class I and HT of stage I–II.
About the Authors
V. G. Tregubov
City hospital № 2, Krasnodar
Russian Federation
Russian Federation
S. G. Kanorskiy
Kuban State Medical University
Russian Federation
Russian Federation
V. M. Pokrovskiy
Kuban State Medical University
Russian Federation
Russian Federation
References
1. Lloyd-Jones D., Adams R.J., Brown T.M. et al. Executive Summary: Heart Disease and Stroke Statistics 2010 Update: A Report From the American Heart Association. Circulation 2010; 121 (12): 948–954.
2. Beckett N.S., Peters R., Fletcher A.E. et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358 (18): 1887–1898.
3. Pfeffer M.A., Braunwald E., Moye L.A. et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992; 327 (10): 669–77.
4. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325 (5): 351–353.
5. Ma T.K., Kan K.K., Yan B.P., Lam Y.Y. Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol 2010; 160 (6): 1273–1292.
6. Ceconi C., Fox K.M., Remme W.J. et al. ACE inhibition with perindopril and endothelial dysfunction. Results of a substudy of EUROPA study: PERTINENT. Cardiovasc Res 2007; 73 (1): 237–246.
7. Gurevich M.A. Arterial hypertension and chronic heart failure — unity of pathogenesis and treatment methods. Rossiyskiy Kardiologicheskiy Zhurnal 2005; 11(6): 91–95. Russian (Гуревич М.А. Артериальная гипертония и хроническая сердечная недостаточность — единство патогенеза и принципов лечения. Российский Кардиологический Журнал 2005; 11(6): 91–95).
8. Trushinskiy Z.K., Dovgalyuk G.R., Skritskaya O.Yu. About correlation between hypertrophy of the left ventricle and disorder in its diastolic function during arterial hypertension. Terapevticheskii arkhiv 2003; 75 (3): 57–59. Russian (Трушинский З.К., Довгалюк Г.Р., Скрицкая О.Ю. О связи между гипертрофией левого желудочка и нарушением его диастолической функции при артериальной гипертонии. Терапевтический архив 2003; 75 (3): 57–59).
9. Agadzhanyan N.A., Bykov A.T., Trukhanov A.I. Modern technologies of rehabilitation medicine. Moscow: Meditsina; 2004. Russian (Агаджанян Н.А., Быков А.Т., Труханов А.И. Современные технологии восстановительной медицины. М.: Медицина; 2004).
10. Law M.R., Morris J.K., Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiologic stadies. BMJ 2009; 338: 1665–1683.
11. Pokrovsky V.M. Heart rhythm formation in the organism of humans and animals. Krasnodar: Kuban-Kniga; 2007. Russian (Покровский В.М. Формирование ритма сердца в организме человека и животных. Краснодар: Кубань-Книга; 2007).
12. Astakhova A.V., Lepakhin V.K., Medication. Adverse drug reactions and safety monitoring. Moscow: Eksmo; 2008. Russian (Астахова А.В., Лепахин В.К. Лекарства. Неблагоприятные побочные реакции и контроль безопасности. М.: Эксмо; 2008).
13. Belousov Yu.B., Leonova M.V. Basics of clinical pharmacology and rational medicamentous therapy. Guide for practicing physicians. Moscow: Bionika; 2002. Russian (Белоусов Ю.Б., Леонова М.В. Ос-новы клинической фармакологи и иррациональной фармакотерапии. Руководство для практикующих врачей. М.: Бионика; 2002).
14. Zborovsky A.B., Tyurenkov I.N. Complications in pharmacotherapy. Moscow: Meditsina; 2004. Russian (Зборовский А.Б., Тюренков И.Н. Осложнения фармакотерапии. М.: Медицина; 2003).
15. Pokrovsky V.M., Ponomarev V.V., Artyushkov V.V., et al. System for determining cardio-respiratory synchronism in a human. 2009; Russia, patent 86860. Russian (Покровский В.М., Пономарев В.В., Артюшков В.В. и др. Система для определения сердечно-дыхательного синхронизма у человека. 2009; Россия, патент 86860).
16. Pokrovsky V.M. Cardio-respiratory synchronism in assessment of regulatory-adaptive capabilities of an organism. Krasnodar: Kuban-Kniga; 2010. Russian (Покровский В.М. Сердечно-дыхательный синхронизм в оценке регуляторно-адаптивных возможностей организма. Краснодар: Кубань-Книга; 2010).
17. Pokrovsky V.M., Potyagaylo E.G., Abushkevich V.G. etal. Cardio-respiratory synchronism: determining in humans, dependency on characteristics of the nervous system and functional conditions of the organism. Uspekhi Fiziologicheskikh Nauk 2003; (3): 68–77. Russian (Покровский В.М., Потягайло Е.Г., Абушкевич В.Г. и др. Сердечно-дыхательный синхронизм: выявление у человека, зависимость от свойств нервной системы и функциональных состояний организма. Успехи Физиологических Наук 2003; (3): 68–77).
18. Pflugfelder P.W., Baird M.G., Tonkon M.J. et al. Clinical consequences of angiotensin–converting enzyme inhibitor withdrawal in chronic heart failure: a double–blind, placebo–controlled study of quinapril. J Am Coll Cardiol 1993; 22 (6): 1557–63.
19. Beynon J.H., Pathy M.S. An open, parallel group comparison of quinapril and captopril, when added to diuretic therapy, in the treatment of elderly patients with heartfailure. Curr Med Res Opin 1997; 13 (10): 583–92.
20. Acanfora D., Furgi G., Trojano L. et al. Quinapril in patients with congestive heart failure: controlled trial versus captopril. Am J Ther 1997; 4 (5–6): 181–8.
21. Pitt B., O’Neill B., Feldman R. et al. QUIET Study Group. The Quinapril Ischemic Event Trial (QUIET) evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function. Am J Cardiol 2001; 87 (9): 1058–63.
22. BelenkovIu.N., Chazova I.E., Mychka V.B. Results of nonmedical interventions in multicenter randomized open study of efficacy of lifestyle modification and therapy with quinapril in patients with obesity and hypertension. Kardiologiia 2004; 44 (4): 14–9. Russian (Беленков Ю.Н., Чазова И.Е., Мычка В.Б. Результаты многоцентрового рандомизированного открытого исследования по изучению эффективности изменения образа жизни и терапии ингибиторами ангиотензинпревращающего фермента (квинаприлом) у больных ожирением и артериальной гипертонией (ЭКО). Кардиология 2004; 44 (4): 14–19).
23. Lopez-Sendon J., Swedberg K., McMurray J.J. et al. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J 2004; 25 (16): 1454–1470.
Review
For citations:
Tregubov V.G., Kanorskiy S.G., Pokrovskiy V.M. INFLUENCE OF QUINAPRIL ON THE REGULATORY-ADAPTIVE STATUS OF PATIENTS WITH CHRONIC HEART FAILURE HYHA CLASS I: RESULTS OF NOT COMPARATIVE STUDY. Rational Pharmacotherapy in Cardiology. 2012;8(4):526-530. (In Russ.) https://doi.org/10.20996/1819-6446-2012-8-4-526-530
Views: 626
Email this article 